Terciprazine

This classification denotes an antihypertensive agent with the molecular formula C22H29F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TCE6830H8P, chemically known as (+-)-alpha-(((1-ethynylcyclohexyl)oxy)methyl)-4-(alpha,alpha,alpha-trifluoro-m-tolyl)-1-piperazineethanol but generally known as terciprazine, which bears US NIH Compound Identifier 68763. European Medicines Agency schedules Terciprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10916MIG. The term TERCIPRAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). TERCIPRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terciprazine under HS 29335995 and SITC 51576. As of Q4 2014, TERCIPRAZINE remains the US FDA Preferred Term for this commodity. Terciprazine bears US NLM identifiers UMLS ID C0610726 and NCI Concept Code C90734. SMILES: FC(F)(F)c1cc(N2CCN(CC(O)COC3(CCCCC3)C#C)CC2)ccc1.